August 10-11, 2017
Grand Hyatt Seattle
721 Pine Street
Seattle, WA 98101

Only practicing US and Canadian interventional cardiologists are eligible to participate.
There is no cost to apply.

Sponsored by the Cardiovascular Research Foundation Supported through educational grants from:

MAJOR BENEFACTORS 
Abbott, ABIOMED, Inc., Boston Scientific Corporation

BENEFACTORS 
Asahi Intecc USA, Inc., Cardiovascular Systems, Inc., Getinge, Medtronic, Spectranetics, St. Jude Medical, Vascular Solutions

Overview

This program is geared toward the interventionalist seeking to increase their knowledge on heart failure treatment, evaluation, and revascularization. In addition, participants will learn how to manage challenging patient subsets, such as high risk CTO patients and depressed LVEF, as well as how to provide optimal hemodynamic support. The use of simulator training will enhance the learning experience for interventionalists and fellows. Expert faculty will offer insights into selecting devices and patients, optimizing technique, and overcoming difficult anatomy. The latest clinical data and guidelines for complex, higher-risk procedures also will be reviewed. Case-based presentations with audience participation will be used to reinforce the latest treatment for patients undergoing CTO. Expert presenters will share techniques and treatments to improve patient care.

Learning Objectives

By the end of this program, participants
will be able to:

  • Explain the role and importance of complete revascularization
  • Apply new techniques and knowledge of device selection in managing patients
  • Identify the benefits of developing a CHIP protected PCI program
  • Discuss the different cases in which advanced techniques will benefit the patients
This educational activity is designed for practicing US and Canadian interventional cardiologists and clinical cardiologists involved in the management of patients with cardiovascular disease requiring hemodynamic support.
Evaluation by questionnaire will address content, presentation effectiveness, possible bias, and future educational needs.

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and therefore, does not compromise the scientific integrity of the educational activity.


Discussion of off-label product usage is made at the sole discretion of the faculty. Off-label product discussion and usage is not endorsed by the Cardiovascular Research Foundation, nor the course directors of this activity.


Faculty participating in medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the activity audience any real or apparent conflicts of interest related to the content of their presentations. Faculty in noncompliance with this policy are not permitted to participate in this activity.

This program is sponsored by the Cardiovascular Research Foundation. The Cardiovascular Research Foundation gratefully acknowledges the following supporters for this program:


MAJOR BENEFACTORS
Abbott
ABIOMED, Inc.
Boston Scientific Corporation
BENEFACTORS
Asahi Intecc USA, Inc.
Cardiovascular Systems, Inc.
Getinge
Medtronic
Spectranetics
St. Jude Medical
Vascular Solutions


The Cardiovascular Research Foundation ensures that its programs are educational and meet the needs of the target audience.

Only practicing US and Canadian interventional cardiologists are eligible to participate. Travel and hotel support will be provided to accepted applicants who fully participate in the program per the acceptance guidelines. There is no cost to apply. This program is not CME accredited.

This activity is not CME accredited, and therefore, the supporter is required under the Sunshine Act (as part of the Affordable Care Act) to track and report all payments and transfers of value to US licensed physicians, including meals and expenses that are provided to you. In order to help supporters comply with the Sunshine Act, the names and contact information of all US and Canadian licensed physicians participating in this function will be provided to the supporter of this program. The information provided will be used for reporting purposes only.


Should you partake in this program, you will be reported as part of the Sunshine Act submission and will appear on the CMS Open Payments website on the next reporting cycle.


VERMONT-LICENSED HCPs

Vermont laws prohibit this program from providing any complimentary food, meals, or refreshments to healthcare professionals licensed by and regularly practicing in Vermont. Accordingly, healthcare professionals licensed by and practicing in Vermont are requested not to apply for this program.

Expanding Your Practice to Include CHIP:
An Interactive Workshop

Faculty

CHAIR


William L. Lombardi, MD University of Washington Medical Center
Seattle, WA

Co-CHAIRS


Ajay J. Kirtane, MD, SMNewYork-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

Claudius Mahr, DOUniversity of Washington
Medical Center
Seattle, WA

Jeffrey W. Moses, MDNew York-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

Jason W. Smith, MDCardiac Surgery Clinic at UWMC
Seattle, WA

INVITED FACULTY


Daniel Burkhoff, MD, PhDNewYork-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

Creighton W. Don, MD, PhDUniversity of Washington
School of Medicine
Seattle, WA

Darshan Doshi, MDNewYork-Presbyterian Hospital/
Columbia University Medical Center
New York, NY

J. Aaron Grantham, MDUniversity of Missouri Kansas City/
Saint Luke's Mid America
Heart Institute
Kansas City, MO

Colm Hanratty, MDBelfast Trust
Belfast, Ireland

Ravi S. Hira, MDUniversity of Washington
Medical Center
Seattle, WA 

Eric V. Krieger, MDUniversity of Washington
Medical Center
Seattle, WA

John M. Lasala, MD, PhDBarnes Jewish Hospital
St. Louis, MO

Ryan Martin, MDUniversity of Washington Medical Center
Seattle, WA

Perwaiz M. Meraj, MDNorthwell Health
Manhasset, NY

William W. O’Neill, MDHenry Ford Hospital
Detroit, MI

Ashish Pershad, MDBanner University
Medical Center Phoenix
Phoenix, AZ

Sunil V. Rao, MDDuke University Medical Center
Durham, NC

Robert F. Riley, MD, MSThe Christ Hospital Heart & Vascular Center and the Lindner Center for Research and Education
Cincinnati, OH

Paul S. Teirstein, MDScripps Clinic and Research Foundation
La Jolla, CA

Jennifer A. Tremmel, MDStanford University Medical Center
Stanford, CA

R. Michael Wyman, MDTorrance Memorial Medical Center
Torrance, CA

Robert W. Yeh, MDBeth Israel Deaconess
Medical Center
Boston, MA

Agenda

{{section.time_start}} {{section.name}} {{section.moderator}} , and {{moder}}

{{section.name}}

Moderators: Moderator: , and {{person}}
{{segment.time_start}} •      {{segment.name}} , and {{mod}}

{{subsection.name}}

{{subsection.time_start}} - {{subsection.time_stop}}
, and {{mod}}
{{segment.time_start}} {{segment.name}} , and {{mod}}

APPLY

There is no cost to apply.

Should you have any questions, please contact Ryo Mochido at chip@crf.org.

Apply TODAY